J.M. Hartwell’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-7,800
Closed -$696K 89
2018
Q1
$696K Buy
7,800
+450
+6% +$43.2K 0.13% 49
2017
Q4
$767K Sell
7,350
-4,400
-37% -$496K 0.14% 45
2017
Q3
$1.71M Buy
11,750
+3,400
+41% +$463K 0.34% 25
2017
Q2
$1.08M Sell
8,350
-1,750
-17% -$214K 0.23% 34
2017
Q1
$1.26M Buy
10,100
+2,500
+33% +$299K 0.27% 29
2016
Q4
$880K Sell
7,600
-575
-7% -$64K 0.22% 32
2016
Q3
$855K Buy
8,175
+2,450
+43% +$265K 0.2% 33
2016
Q2
$565K Buy
5,725
+3,725
+186% +$385K 0.14% 51
2016
Q1
$200K Buy
+2,000
New +$206K 0.05% 80
2015
Q2
Sell
-30,545
Closed -$3.52M 117
2015
Q1
$3.52M Buy
30,545
+14,550
+91% +$1.74M 0.76% 23
2014
Q4
$1.79M Buy
+15,995
New +$1.69M 0.42% 26

Other funds holding CELG

J.M. Hartwell's CELG Position: Q2 2018 in Review

J.M. Hartwell sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 7,800 shares — an estimated $696K sold.

J.M. Hartwell first reported a position in CELG in Q4 2014 and held it in 11 quarters. The position peaked at $3.52M in Q1 2015. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • J.M. Hartwell reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
  • J.M. Hartwell sold 7,800 Celgene Corp shares in Q2 2018, an estimated $696K.
  • J.M. Hartwell first reported a position in Celgene Corp in Q4 2014 and held it in 11 quarters.
  • J.M. Hartwell's Celgene Corp position peaked at $3.52M in Q1 2015.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on J.M. Hartwell's 13F filing for Q2 2018, filed 13 Jul 2018.